The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
Advancing the drug development process in metastatic prostate cancer through machine learning.
 
David Alan Quigley
No Relationships to Disclose
 
Julian C. Hong
Research Funding - Roche (Inst)
 
Nicholas Lillis
No Relationships to Disclose
 
Ali Sabbagh
No Relationships to Disclose
 
Isabel D Friesner
No Relationships to Disclose
 
Adina Bailey
No Relationships to Disclose
 
Rahul Raj Aggarwal
Consulting or Advisory Role - Alessa Therapeutics; Amgen; AstraZeneca; Bayer; BioXcel Therapeutics; Boxer Capital; EcoR1 Capital; Exelixis; Janssen; Jubilant Pharmaceuticals; Merck; Novartis; OncLive.; PCCTC; Pfizer; Tersera
Research Funding - Amgen (Inst); AstraZeneca (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Xynomic Pharma (Inst); Zenith Epigenetics (Inst)
Expert Testimony - University of Utah Health
Travel, Accommodations, Expenses - DAVA Oncology
 
Li Zhang
No Relationships to Disclose
 
Meera Reddy Chappidi
No Relationships to Disclose
 
Hari Singhal
Employment - Johnson & Johnson
 
Joel Greshock
No Relationships to Disclose
 
Ke Zhang
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
Research Funding - Johnson & Johnson
 
Margaret K. Yu
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
Patents, Royalties, Other Intellectual Property - Johnson & Johnson
 
Eric J. Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics; Teon Therapeutics
Honoraria - Janssen; Johnson and Johnson
Consulting or Advisory Role - Fortis; Janssen Oncology; Teon Therapeutics